Procter & Gamble Company (The) (NYSE:PG - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twenty-four ratings firms that are covering the company, Marketbeat.com reports. Ten investment analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $161.70.
A number of brokerages recently weighed in on PG. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $164.00 to $162.00 and set an "overweight" rating for the company in a report on Thursday, July 16th. TD Cowen restated a "hold" rating and issued a $150.00 price objective on shares of Procter & Gamble in a research report on Wednesday, September 30th. BMO Capital Markets upped their price objective on Procter & Gamble from $169.00 to $170.00 and gave the stock an "outperform" rating in a report on Monday, June 29th. Royal Bank Of Canada reduced their price objective on Procter & Gamble from $167.00 to $166.00 and set an "outperform" rating on the stock in a report on Tuesday, October 6th. Finally, Bank of America decreased their price objective on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating on the stock in a research report on Friday, July 10th.
View Our Latest Research Report on PG
Insider Activity at Procter & Gamble
In related news, CEO Paul Gama sold 2,225 shares of the firm's stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the transaction, the chief executive officer owned 51,124 shares in the company, valued at $7,430,362.16. This trade represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of Procter & Gamble stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $344,310.46. Following the completion of the sale, the insider owned 30,730 shares of the company's stock, valued at approximately $4,466,298.20. The trade was a 7.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock valued at $2,189,970 over the last quarter. 0.23% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. JGP Wealth Management LLC boosted its stake in shares of Procter & Gamble by 4.7% in the 3rd quarter. JGP Wealth Management LLC now owns 45,863 shares of the company's stock valued at $6,663,000 after purchasing an additional 2,055 shares during the last quarter. Scott Capital Advisors LLC acquired a new stake in shares of Procter & Gamble during the 3rd quarter worth approximately $468,000. Burkett Asset Management Ltd raised its stake in shares of Procter & Gamble by 7.5% during the third quarter. Burkett Asset Management Ltd now owns 3,435 shares of the company's stock worth $499,000 after buying an additional 240 shares during the last quarter. Wealth Enhancement Trust Services Inc. raised its stake in shares of Procter & Gamble by 4.5% during the third quarter. Wealth Enhancement Trust Services Inc. now owns 25,097 shares of the company's stock worth $3,646,000 after buying an additional 1,091 shares during the last quarter. Finally, Bangor Savings Bank raised its stake in shares of Procter & Gamble by 80.7% during the third quarter. Bangor Savings Bank now owns 6,123 shares of the company's stock worth $890,000 after buying an additional 2,735 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Trading Down 0.1%
PG opened at $152.99 on Wednesday. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $355.33 billion, a PE ratio of 23.11, a PEG ratio of 3.81 and a beta of 0.39. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $167.25. The firm has a 50-day moving average price of $146.21 and a two-hundred day moving average price of $146.23.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping analysts' consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. During the same period in the previous year, the firm posted $1.48 earnings per share. The company's revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities analysts anticipate that Procter & Gamble will post 6.98 earnings per share for the current fiscal year.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Dividend reaffirmed: P&G’s board declared a quarterly dividend of $1.0885 per share, payable November 16 to shareholders of record October 23. The announcement reinforces PG’s appeal to income-focused investors and its long record of dividend growth. P&G Declares Quarterly Dividend
- Positive Sentiment: Potentially attractive valuation: Recent commentary argues that PG trades below its historical average and could be roughly 22% undervalued based on its ability to generate cash. The company’s broad portfolio of essential brands, including Tide, Pampers, Gillette and Crest, supports the defensive investment case. Procter & Gamble Stock May Be 22% Undervalued After $1.5B Investment
- Positive Sentiment: Long-term investor support: Analysts and opinion writers continue to favor PG as a “Dividend King,” arguing that stable cash flows and shareholder distributions could produce competitive total returns even if a smaller rival grows faster. Why I Just Invested in This Dividend King
- Neutral Sentiment: Coverage points to improving business trends and a potentially better growth outlook, but the available reports provide limited new operating detail. Investor focus is likely to remain on upcoming results, organic sales growth and guidance.
- Negative Sentiment: Growth and valuation concerns: PG’s fiscal 2026 sales reached $87.0 billion, but its mature consumer-staples profile can limit growth. At roughly 23 times earnings, investors may be questioning whether the current valuation adequately compensates for slower expansion and execution risks.
Procter & Gamble Company Profile
(
Get Free Report)
The Procter & Gamble Company NYSE: PG is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.
Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.
Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.